Objective: Intermediate care units provide a high level of care to complex patients and are becoming increasingly popular in North America. Despite the growing popularity of Intermediate care units, very little is known about them. This study explored a typical Intermediate care unit, identifying patient characteristics including demographics, comorbidities, length of stay, as well as primary and secondary diagnosis and mortality.Results: A total of 200 patients chart were reviewed, of which, 102 were male, and 89 patients were younger than 65 years old. Diabetes, hypertension, and chronic obstructive pulmonary disease were common among patients with a prevalence of 33.5%, 56%, and 32.5%, respectively. Alcohol use disorder, asthma, liver disease and IV drug abuse were much more common in patients younger than 65 years. The average length of stay was 5.31 days regardless of age. Almost two-thirds of the patients in the Intermediate care unit were admitted directly from the emergency room. The mortality rate among the patients studied was 9.5%. The most common admitting diagnosis was respiratory diseases such as chronic obstructive pulmonary disease or Pneumonia (38.0%), followed by cardiac disorders which were predominantly arrhythmias and congestive heart failure (27.0%).
High-acuity patients occasionally require advanced resources and monitoring, but do not qualify for intensive care admission in large intensive care unit (ICU). For these patients, intermediate care units (IMCUs) can provide adequate care. IMCUs lessen the patient burden for both the general ward and the ICU, allowing for more free beds in the ICU and ward. The main purpose of this study was to explore typical patient characteristics/demographics of patients admitted to an IMCU from the emergency room (ER) and mortality rate. This study is a retrospective cross-sectional study of a medical surveillance unit (MSU), which is an IMCU located in Pasqua Hospital, Regina. All patients admitted to the MSU from the ER in 2017 and 2018 were included in the study. This study retrospectively reviewed 715 patients in total. Patients' age, sex, discharge disposition, comorbidities, primary and secondary diagnoses, admission and discharge date to/from the MSU, Acute Physiology and Chronic Health Evaluation II (APACHE II) score, early assessment and response system (EARS) score, and acuity score were recorded. A total of 715 patient charts were reviewed for this study, with 323 patients in 2017 and 392 patients in 2018. Approximately a third of the study participants were diabetic, and half were hypertensive. Male sex had higher comorbidities including asthma or cerebrovascular accidents, and women had been diagnosed with coronary heart disease or liver disease. Both male and female were equally affected by substance use. 25.6% of the study population were smokers, 15.5% were intravenous drugs, and 16.8% were suffering with alcohol use disorder. Respiratory diseases account for a quarter of all primary diagnoses made in the MSU. Overall mortality rate was 5.9%. The APACHE II, EARS, and acuity scores were significantly different between deceased and alive patients (p < 0.001, p < 0.007, and p < 0.001, respectively). Half of the patients were discharged to home and a quarter were transferred to the ward. Nearly two-third of the study population was not readmitted to hospital within 30 days. This is one of the first studies to describe IMCU patients characteristics transferred from the ER in Canada. The APACHE II, EARS, and acuity scores were found significantly different between deceased and alive patients. These scores could therefore be used to develop tools that can identify high-risk patients for equitable allocation of healthcare resources to reduce mortality. Keywords Medical surveillance unit. Quality of care. Intermediate care unit. Modified early warning score This article is part of the Topical Collection on Medicine
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.